Successful managerial track record at regional CEO level in international corporations (e.g. Novartis) as well as at Partner level in VC/PE.
Originated and executed vast portfolio of m&a/investment transactions. Led turnarounds with spectacular results.
Lived/ worked in Latin America, China, Russia, Europe.
Co-founded Orphinic Scientific, a drug development company. Orphinic focuses on mid market and orphan disease opportunities in late preclinical and phase 1 and 2 of clinical trials.
Finished professional courses at Harvard Business School, London Business School and Wharton.